Galapagos NV (AMS:GLPG)
28.60
-0.48 (-1.65%)
Jan 28, 2026, 5:35 PM CET
Galapagos NV Employees
Galapagos NV had 558 employees as of June 30, 2025. The number of employees decreased by 146 or -20.74% since the number was reported on December 31, 2024.
Employees
558
Change
-146
Growth
-20.74%
Revenue / Employee
€407,558
Profits / Employee
€619,254
Market Cap
1.92B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 558 | -146 | -20.74% |
| Dec 31, 2024 | 704 | -419 | -37.31% |
| Dec 31, 2023 | 1,123 | -215 | -16.07% |
| Dec 31, 2022 | 1,338 | 29 | 2.22% |
| Dec 31, 2021 | 1,309 | -180 | -12.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Arcadis NV | 32,059 |
| Signify | 29,459 |
| Havas | 22,841 |
| Koninklijke BAM Groep nv | 13,082 |
| Aperam | 12,007 |
| Basic-Fit | 8,937 |
| AMG Critical Materials | 3,651 |
| Theon International | 633 |
Galapagos NV News
- 22 days ago - Galapagos (GLPG) to Cease Cell Therapy Operations - GuruFocus
- 22 days ago - Galapagos Announces Board Decision to Initiate Wind-Down of Cell Therapy Activities - GlobeNewsWire
- 5 weeks ago - Galapagos: Pivoting From Clinical Risk To Strategic Capital Allocation - Seeking Alpha
- 5 weeks ago - Galapagos (GLPG) Achieves Key Milestone in Dermatomyositis Study - GuruFocus
- 6 weeks ago - GLPG Crosses Above Average Analyst Target - Nasdaq
- 7 weeks ago - Galapagos (GLPG) Showcases Promising Phase 2 Results for CAR T-Cell Therapy - GuruFocus
- 7 weeks ago - Galapagos Presented New ATALANTA-1 Cell Therapy Data in MCL at ASH 2025 - GlobeNewsWire
- 2 months ago - Galapagos Receives Transparency Notifications from Bank of America - GlobeNewsWire